Celecoxib, a selective cyclooxygenase 2 inhibitor, protects against human epidermal growth factor receptor 2 (HER-2)/neu-induced breast cancer

Louise R. Howe, Kotha Subbaramaiah, Jay Patel, Jaime L. Masferrer, Aparna Deora, Clifford Hudis, Howard T. Thaler, William J. Muller, Baoheng Du, Anthony M.C. Brown, Andrew J. Dannenberg

Research output: Contribution to journal › Article › peer-review

201 Scopus citations

Fingerprint

Dive into the research topics of 'Celecoxib, a selective cyclooxygenase 2 inhibitor, protects against human epidermal growth factor receptor 2 (HER-2)/neu-induced breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences